These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7046344)

  • 41. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.
    Scali C; Giovannini MG; Bartolini L; Prosperi C; Hinz V; Schmidt B; Pepeu G
    Eur J Pharmacol; 1997 May; 325(2-3):173-80. PubMed ID: 9163564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemistry of metrifonate and dichlorvos.
    Hofer W
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():7-14. PubMed ID: 7344414
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
    Heinig R; Sachse R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metrifonate. A viewpoint.
    Taylor P
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413708
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasma levels of metrifonate and dichlorvos during treatment of schistosomiasis with bilarcil.
    Nordgren I; Holmstedt B; Bengtsson E; Finkel Y
    Am J Trop Med Hyg; 1980 May; 29(3):426-30. PubMed ID: 7386721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior.
    Riekkinen M; Schmidt B; Kuitunen J; Riekkinen P
    Eur J Pharmacol; 1997 Mar; 322(1):1-9. PubMed ID: 9088863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methodological commentary on the analysis of metrifonate and dichlorvos in biological samples.
    Aden Abdi Y; Villén T; Gustafsson LL; Ericsson O; Sjöqvist F
    J Chromatogr; 1993 Feb; 612(2):336-7; discussion 338-9. PubMed ID: 8468395
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease.
    Pettigrew LC; Bieber F; Lettieri J; Wermeling DP; Schmitt FA; Tikhtman AJ; Ashford JW; Smith CD; Wekstein DR; Markesbery WR; Orazem J; Ruzicka BB; Mas J; Gulanski B
    J Clin Pharmacol; 1998 Mar; 38(3):236-45. PubMed ID: 9549662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate.
    Riekkinen M; Schmidt BH; Riekkinen P
    Eur J Pharmacol; 1997 Nov; 338(2):105-10. PubMed ID: 9455990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metrifonate. A viewpoint.
    Giacobini E
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413707
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of metrifonate on blood cholinesterases in children during the treatment of schistosomiasis.
    Davis RP; Bailey DR
    Bull World Health Organ; 1972; 46(6):747-59. PubMed ID: 4538536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of metrifonate on the hippocampal theta rhythm of freely moving intact and MS-lesioned mice.
    Ikonen S; Tanila H
    Pharmacol Biochem Behav; 2001; 69(1-2):165-72. PubMed ID: 11420082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats.
    Riekkinen P; Schmidt B; Riekkinen M
    Eur J Pharmacol; 1997 Mar; 323(1):11-9. PubMed ID: 9105871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats.
    Riekkinen P; Schmidt B; Stefanski R; Kuitunen J; Riekkinen M
    Eur J Pharmacol; 1996 Aug; 309(2):121-30. PubMed ID: 8874130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-performance liquid chromatographic method using ultraviolet detection for measuring metrifonate and dichlorvos levels in human plasma.
    Unni LK; Hannant ME; Becker RE
    J Chromatogr; 1992 Jan; 573(1):99-103. PubMed ID: 1564112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.
    Mega MS; Cummings JL; O'Connor SM; Dinov ID; Reback E; Felix J; Masterman DL; Phelps ME; Small GW; Toga AW
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):63-8. PubMed ID: 11234910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats.
    Hinz VC; Kolb J; Schmidt BH
    Neurochem Res; 1998 Jul; 23(7):931-8. PubMed ID: 9690734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical pharmacology of metrifonate.
    Jann MW
    Pharmacotherapy; 1998; 18(2 Pt 2):55-67; discussion 79-82. PubMed ID: 9543466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metrifonate.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Dec; 11(6):490-6. PubMed ID: 9413706
    [No Abstract]   [Full Text] [Related]  

  • 60. Circadian rhythms of RNA, DNA and protein in the rat thyroid, adrenal and testis in chronic pesticide exposure. III. Effects of the insecticides (dichlorvos and trichlorphon).
    Nicolau GY
    Physiologie; 1983; 20(2):93-101. PubMed ID: 6196799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.